Evidence map›Paper›PMID 37936642›Full record

ArticleRSC advances2023

Synthesis of novel benzopyrimido[4,5-

Mohamed M Hammouda, Kamal Shalabi, Abdulaziz A Alanazi, Khaled M Elattar, Maged A Azzam, Marwa M Rashed

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Bacterial responses toRSC advances · 2025
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mohamed M HammoudaDepartment of Chemistry, College of Science and Humanities in Al-Kharj, Prince Sattam Bin Abdulaziz University Al-Kharj 11942 Saudi Arabia m.elmettwaly@psau.edu.sa +966 570260397.ORCID https://orcid.org/0009-0004-2721-4807
Kamal ShalabiDepartment of Chemistry, College of Science and Humanities in Al-Kharj, Prince Sattam Bin Abdulaziz University Al-Kharj 11942 Saudi Arabia m.elmettwaly@psau.edu.sa +966 570260397.
Abdulaziz A AlanaziDepartment of Chemistry, College of Science and Humanities in Al-Kharj, Prince Sattam Bin Abdulaziz University Al-Kharj 11942 Saudi Arabia m.elmettwaly@psau.edu.sa +966 570260397.
Khaled M ElattarUnit of Genetic Engineering and Biotechnology, Faculty of Science, Mansoura University El-Gomhoria Street Mansoura 35516 Egypt khaledelattar2@yahoo.com.ORCID https://orcid.org/0000-0002-3426-3373
Maged A AzzamDepartment of Chemistry, College of Science and Humanities in Al-Kharj, Prince Sattam Bin Abdulaziz University Al-Kharj 11942 Saudi Arabia m.elmettwaly@psau.edu.sa +966 570260397.
Marwa M RashedToxicology Department, Mansoura Hospital, Faculty of Medicine, Mansoura University El-Gomhoria Street Mansoura 35516 Egypt marwarashed@mans.edu.eg.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present work reported the synthesis of novel benzopyrimido[4,5-

Identifiers

PMID37936642
PMCPMC10626315

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.